CD79A and influenza: According to the manufacturer (instruction for use), cross-reactivity causes 3.4% and 8.6% of people vaccinated against influenza to test false-positive for SARS-CoV-2 antibodies in the blood (anti-SARS-CoV-2 IgG and anti-SARS-CoV-2 IgA, respectively).